Home
About Us
Overview
Leadership
Board of Directors
Programs
Publications
All Publications
Tamibarotene
SY-2101
SY-5609
Investors & Media
Contact
Investors & Media
Investors & Media
Overview
News
Email Alerts
Press Releases
Events & Presentations
IR Calendar
Presentations
Company Info
Profile
Leadership
Contacts
Analyst Coverage
FAQ
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Annual Reports
IRS Tax Form 8937
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Filings
Quarterly Reports
Proxy
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Investor & Media Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Annual Filings
SEC Filings
Overview
All SEC Filings
Annual Filings
Quarterly Reports
Proxy
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
ARS
Year:
View All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Date
Form
Description
PDF
XBRL
Pages
03/20/17
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-10.12
EX-10.13
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
179
1
2